Lam Research Corp. filings document regulatory disclosures for a semiconductor wafer fabrication equipment company. Its Form 8-K reports include operating results and financial-condition updates, material-event disclosures, exhibits for quarterly earnings releases, governance matters, capital-structure items, and changes affecting security-holder rights.
Lam Research proxy and related filings cover annual meeting proposals, director elections, executive compensation advisory votes, stock incentive plan approvals, auditor ratification, charter amendments, stockholder proposals, and changes in the company’s independent registered public accounting firm.
LAM Research (LRCX) reported an insider transaction by a director. On 11/07/2025, the director acquired 1,635 shares of common stock at $0.
After the transaction, the director beneficially owned 109,995 shares, held directly. The reported total includes shares subject to unvested restricted stock units.
Lam Research (LRCX) reported director insider activity. On 11/06/2025, the director transferred 2,950 common shares to the Sohail Family Trust at $0 (Code G), shifting those holdings from direct to indirect. Following the transfer, direct ownership for that lot moved to 0, while the trust held 33,580 shares indirectly. The reporting person remains the beneficial owner of the securities held by the trust.
On 11/07/2025, the director acquired 1,635 common shares at $0 (Code A), bringing direct beneficial ownership to 1,635. The reported totals include shares subject to unvested restricted stock units.
Lam Research Corporation filed a Form S-8 to register up to 96,800,000 shares of its common stock, par value $0.001 per share, issuable pursuant to the Lam Research Corporation 2025 Stock Incentive Plan. These shares may be issued as equity compensation to eligible participants under the plan.
The filing also outlines standard Delaware indemnification provisions for directors and officers, and includes exhibits such as the 2025 Plan, legal opinion, auditor consent, and filing fee table.
Lam Research (LRCX) reported results of its Nov 4, 2025 annual meeting. Stockholders approved the Lam 2025 Stock Incentive Plan and an amendment to the Restated Certificate of Incorporation to limit the liability of certain officers to the fullest extent permitted by Delaware law. The amendment became effective upon filing with Delaware on November 4, 2025, and the company also filed a Restated Certificate that integrated prior amendments.
All director nominees were elected. “Say on Pay” was approved with 90.83% of votes cast. The new stock plan was approved with 93.79% of votes cast. KPMG LLP was ratified as independent auditor with 99.35% of votes cast. A shareholder proposal on special meeting rights received 41.36% support and was not approved.
Lam Research (LRCX) director reported a sale of 1,298 shares of common stock on 11/03/2025 at $159.99 per share (Transaction Code S). The trade was made pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024.
After the sale, the reporting person beneficially owned 1,652 shares directly and 28,930 shares indirectly held by a trust.
Lam Research (LRCX) director reported a Form 4 reflecting a tax withholding transaction. On 10/31/2025, 664 shares of common stock were withheld under transaction code F at a price of $157.46 per share. The filing states these shares were automatically withheld upon vesting of restricted stock units to satisfy tax obligations. Following the transaction, the reporting person beneficially owned 8,029 shares, held directly.
Lam Research (LRCX) reported insider transactions by its Chief Legal Officer. On 10/27/2025, the officer sold 3,000 shares of common stock at $157.48, exercised employee stock options for 6,010 shares at an exercise price of $77.039, and sold 6,010 shares at $157.46.
Following these transactions, the officer beneficially owned 56,786.455 shares directly, which includes shares subject to unvested restricted stock units. The filing shows 12,020 derivative securities (employee stock options) remaining, expiring on 08/05/2031. The options referenced became exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.
Lam Research (LRCX) reported stronger quarterly results. Revenue reached $5.324 billion, up from $4.168 billion a year ago, driven by higher systems sales and ongoing service demand. Gross margin improved to 50.4%, and net income rose to $1.569 billion with diluted EPS of $1.24. Operating income was $1.829 billion.
Systems revenue was $3.548 billion and customer support-related revenue was $1.777 billion. By region, China generated $2.283 billion, Taiwan $1.027 billion, and Korea $0.776 billion. Foundry represented 60% of leading/non-leading-edge equipment and upgrades, Memory 34%, and Logic/IDM 6%. Cash and cash equivalents were $6.693 billion, supported by $1.779 billion in operating cash flow. The company returned capital through $975.8 million of share repurchases and $292.0 million in dividends. Deferred revenue ended at $2.769 billion. Shares outstanding were 1,256,030 thousand as of October 22, 2025.
Lam Research Corporation furnished an Item 2.02 Form 8‑K stating it issued a press release announcing financial results for the fiscal quarter ended September 28, 2025.
The press release is attached as Exhibit 99.1 and, along with Item 2.02, is furnished and not deemed filed under the Exchange Act, nor incorporated by reference. The filing notes the Company’s common stock (LRCX) is listed on the Nasdaq Global Select Market.
Lam Research (LRCX): Insider transaction disclosed. A Senior Vice President reported an open‑market sale of 52,190 shares of common stock on 10/13/2025 at $138.9 per share (Transaction Code: S). The filing states the trade was effected under a Rule 10b5-1 trading plan adopted on June 11, 2025.
Following the sale, the officer beneficially owns 251,047 shares, held directly. The reported total includes shares subject to unvested restricted stock units. This filing reflects a personal share sale and ownership update by a company officer.